Smartleaf Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Smartleaf Asset Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53K	Hold	50	–	–	﹤0.01%	2892
2026 Q1	$2.63K	Hold	50	–	–	﹤0.01%	2887
2025 Q4	$3.13K	Sell	50 -370	-88%	-$22.8K	﹤0.01%	2850
2025 Q3	$25K	Buy	420 +370	+740%	+$22.6K	﹤0.01%	1721
2025 Q2	$3.1K	Hold	50	–	–	﹤0.01%	2202
2025 Q1	$2.97K	Hold	50	–	–	﹤0.01%	2371
2024 Q4	$2.92K	Hold	50	–	–	﹤0.01%	2424
2024 Q3	$2.94K	Buy	+50	New	+$2.85K	﹤0.01%	2344

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Smartleaf Asset Management's IHI Position: Q2 2026 in Review

Smartleaf Asset Management held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 50 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #2892.

Smartleaf Asset Management first reported a position in IHI in Q3 2024 and has held it in 8 quarters since. The position peaked at $25K in Q3 2025. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Smartleaf Asset Management held 50 shares of iShares US Medical Devices ETF worth $2.53K as of Q2 2026.
Smartleaf Asset Management left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2892 holding.
Smartleaf Asset Management first reported a position in iShares US Medical Devices ETF in Q3 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's iShares US Medical Devices ETF position peaked at $25K in Q3 2025.
500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.